Design Therapeutics
DSGN
#7170
Rank
A$0.87 B
Marketcap
A$13.63
Share price
-3.22%
Change (1 day)
5.40%
Change (1 year)

Earnings for Design Therapeutics (DSGN)

Earnings in 2026 (TTM): -A$0.12 Billion

According to Design Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$0.13 Billion a decrease over its 2024 earnings that were of -A$94.25 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Design Therapeutics from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.12 Billion-0.31%
2025 -A$0.13 Billion27.39%
2024 -A$94.25 Million-20.22%
2023 -A$0.12 Billion15.68%
2022 -A$0.11 Billion88.64%
2021 -A$54.14 Million330.14%
2020 -A$12.59 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-A$0.24 Billion 89.76%๐Ÿ‡บ๐Ÿ‡ธ USA